ELISpot and FluoroSpot Assay Market size is projected to reach USD 390 million by 2027 from USD 274 million in 2022, at a CAGR of 7.3% during the forecast period according to a new report by MarketsandMarkets™. Market is driven by factors such as global prevalence of chronic and infectious diseases and the growing awareness for early disease diagnosis, the rising use of ELISpot assays as diagnostic tool in drug hypersensitivity reaction. On the other hand, a unpermissive requirements for approval of ELISpot and FluoroSpot assay instruments and consumables is expected to limit market growth to a certain extent in the coming years.
© Copyright 2021 - by Bookmarkingpage.com